Name | Class | Normal Concentration (Average) | Uremic Concentration (Average) | Relative increase | Pathological associations |
1-Methylguanosine | water-soluble | 13.70 (+/-16.90) µg/L, [n=10] | 41.60 (+/-23.80) µg/L, [n=17] | 3.04 | unknown [1]
|
Hyaluronic acid (Hyaluronan) | middle | 124.00 µg/L, [n=86] | 215.26 (+/-233.97) (17.00-1843.00) µg/L, [n=222], D:D | 1.74 | other [1] Nephrologic [1]
|
β-2-Microglobulin | middle | 1.50 (+/-0.50) (1.10-2.40) mg/L, [n=47], p=0.00, D:A | 32.62 (+/-8.00) (13.00-100.00) mg/L, [n=769], p=0.00, D:B | 21.80 | Osteoarticular [3] other [1]
|
1-Methyladenosine | water-soluble | 17.10 (+/-5.10) µg/L, [n=10] | 104.00 (+/-56.20) µg/L, [n=17] | 6.08 | Oncologic [3] Hematologic [1] Cardiovascular [1]
|
Motiline | middle | 25.40 (+/-2.80) ng/L, [n=2] | 425.56 (+/-241.12) (201.00-672.10) ng/L, [n=36], p=0.00, D:B | 16.75 | Oncologic [1]
|
Leptin | protein-bound | 7.90 (+/-4.81) (0.60-54.40) µg/L, [n=133], p=0.08, D:D | 20.30 (+/-20.69) (0.10-724.10) µg/L, [n=242], p=0.00, D:D | 2.57 | Nutrition [2] Nephrologic [2] Immunologic [1]
|
Cholecystokinin | middle | 4.99 (+/-2.23) ng/L, [n=43] | 26.06 (+/-22.91) (6.73-131.50) ng/L, [n=77], p=0.00, D:C | 5.22 | Nutrition [1]
|
Guanidinosuccinic acid | water-soluble | 0.03 (+/-0.01) mg/L, [n=16] | 2.99 (+/-1.72) (0.99-47.00) mg/L, [n=63], p=0.00, D:D | 99.74 | Neurologic and CNS [2]
|
Monomethylamine | water-soluble | 149.94 (+/-26.09) (30.90-320.00) µg/L, [n=17], p=0.00, D:C | 195.76 (+/-50.85) (84.20-580.00) µg/L, [n=40], p=0.00, D:B | 1.31 | Neurologic and CNS [1] Nephrologic [1]
|
Methylguanidine | water-soluble | 7.30 µg/L, [n=24] | 266.30 (+/-227.54) (72.27-1820.00) µg/L, [n=25], D:D | 36.48 | Neurologic and CNS [1] Cardiovascular [1]
|
Myoinositol | water-soluble | 10.00 mg/L, [n=8] | 62.70 (+/-42.92) (43.92-94.00) mg/L, [n=32], p=0.01, D:A | 6.27 | Neurologic and CNS [1]
|
Creatinine | water-soluble | 9.68 (+/-0.24) (8.86-12.00) mg/L, [n=851], p=0.00, D:A | 136.00 (+/-46.00) (?-240.00) mg/L, [n=19746] | 14.04 | Neurologic and CNS [1]
|
p-Cresylsulfate (free) | protein-bound | 0.08 (+/-0.09) mg/L, [n=1] | 2.60 (+/-5.10) mg/L, [n=139] | 32.50 | Nephrologic [2] Cardiovascular [1]
|
Indoxyl sulfate (free) | protein-bound | 0.53 (+/-0.29) mg/L, [n=15] | 3.83 (+/-2.46) (2.09-4.49) mg/L, [n=213], p=0.00, D:A | 7.19 | Nephrologic [2]
|
Trimethylamine | water-soluble | 24.66 (+/-7.31) µg/L, [n=10] | 82.01 (+/-28.49) µg/L, [n=10] | 3.33 | Nephrologic [1]
|
Dimethylamine | water-soluble | 2.18 (+/-0.33) mg/L, [n=9] | 10.32 (+/-1.55) mg/L, [n=7] | 4.73 | Nephrologic [1]
|
Guanidine | water-soluble | 11.80 µg/L, [n=16] | 126.40 (+/-52.60) (90.86-800.00) µg/L, [n=33], D:D | 10.71 | Immunologic [1] Neurologic and CNS [1] Cardiovascular [1]
|
Retinol Binding Protein (RBP) | protein-bound | 20.70 (+/-4.53) mg/L, [n=16] | 194.06 (+/-72.80) (192.00-369.20) mg/L, [n=130], p=0.76, D:A | 9.38 | Immunologic [1]
|
Pseudouridine | water-soluble | 0.55 (+/-4.10) (0.50-0.61) mg/L, [n=60], p=0.00, D:A | 11.55 (+/-8.08) (8.60-86.60) mg/L, [n=53], p=0.30, D:D | 20.80 | Endocrinology [1]
|
Homocysteine | protein-bound | 1.42 (+/-0.50) (1.26-1.88) mg/L, [n=99], p=0.11, D:A | 6.11 (+/-4.70) (4.40-26.40) mg/L, [n=101], p=0.12, D:B | 4.31 | Cardiovascular [4]
|
Adrenomedullin | middle | 13.20 (+/-4.60) ng/L, [n=17] | 88.77 (+/-17.71) (41.80-225.00) ng/L, [n=39], p=0.00, D:B | 6.73 | Cardiovascular [4]
|
Adiponectin | middle | 8.70 (+/-4.80) mg/L, [n=22] | 17.71 (+/-6.60) (15.00-22.20) mg/L, [n=378], p=0.05, D:A | 2.04 | Cardiovascular [3] other [1] Endocrinology [1] Oncologic [1]
|
Indoxyl sulfate (total) | protein-bound | 0.54 (+/-4.00) (0.40-0.60) mg/L, [n=73], p=1.00, D:A | 37.07 (+/-26.50) (0.23-53.58) mg/L, [n=344], p=0.01, D:C | 68.34 | Cardiovascular [2] Nephrologic [2]
|
Urea | water-soluble | 0.30 (+/-0.12) (0.30-0.40) g/L, [n=21], D:A | 1.57 (+/-0.64) (1.30-4.60) g/L, [n=64], p=0.00, D:B | 5.23 | Cardiovascular [2]
|
Asymetric Dimethylarginine (ADMA) | water-soluble | 0.15 (+/-0.08) (0.07-0.28) mg/L, [n=62], p=0.00, D:B | 0.38 (+/-0.27) (0.10-7.30) mg/L, [n=220], p=0.00, D:D | 2.60 | Cardiovascular [2]
|
p-Cresylsulfate (total) | protein-bound | 1.87 (+/-2.31) (1.50-3.80) mg/L, [n=31], p=0.18, D:A | 23.00 (+/-16.90) (18.90-37.70) mg/L, [n=216], p=0.00, D:A | 12.27 | Cardiovascular [1] Nephrologic [1]
|
Phenylacetic acid | protein-bound | 1.40 mg/L, [n=1] | 474.64 (+/-44.88) mg/L, [n=41] | 339.03 | Cardiovascular [1] Immunologic [1]
|
Endothelin | middle | 20.80 (+/-3.80) ng/L, [n=23] | 31.80 (+/-23.01) (3.00-63.00) ng/L, [n=25], p=0.00, D:C | 1.53 | Cardiovascular [1] Endocrinology [1]
|
Xanthine | water-soluble | 0.50 (+/-1.40) mg/L, [n=180] | 1.27 (+/-0.71) (0.45-1.50) mg/L, [n=83], p=0.01, D:B | 2.54 | Cardiovascular [1]
|
Neuropeptide Y | middle | 10.18 (+/-1.73) ng/L, [n=15] | 90.24 (+/-48.13) (64.08-862.94) ng/L, [n=306], p=0.00, D:D | 8.86 | Cardiovascular [1]
|
Parathyroid hormone | middle | 0.51 (+/-0.03) µg/L, [n=30] | 0.31 (+/-0.26) (0.22-1.20) µg/L, [n=230], p=-0.00, D:B | 0.60 | Cardiovascular [1]
|
S-Adenosylhomocysteine | water-soluble | 7.26 (+/-2.14) (3.84-10.68) µg/L, [n=2], D:A | 230.40 (+/-38.40) µg/L, [n=1] | 31.74 | Cardiovascular [1]
|
Atrial Natriuretic Peptide (ANP) | middle | 27.88 (+/-10.09) (27.72-28.00) ng/L, [n=40], p=0.95, D:A | 197.18 (+/-123.82) (187.88-202.00) ng/L, [n=41], p=0.80, D:A | 7.07 | Cardiovascular [1]
|
Resistin | middle | 17.30 (+/-1.00) µg/L, [n=19] | 27.50 (+/-1.40) µg/L, [n=38] | 1.59 | Cardiovascular [1]
|
Symetric Dimethylarginine (SDMA) | water-soluble | 85.25 (+/-38.57) (74.74-129.28) µg/L, [n=100], p=0.00, D:A | 623.24 (+/-324.56) (305.02-1232.20) µg/L, [n=107], p=0.00, D:B | 7.31 | Cardiovascular [1]
|
Dihydroxyphenylalanine (PB-DOPA) | protein-bound | 6.60 (+/-0.73) mg/L, [n=21] | 11.37 (+/-3.17) mg/L, [n=19] | 1.72 | Biochemical [1]
|
Ethylamine | water-soluble | 25.80 (+/-5.80) µg/L, [n=10] | 69.00 (+/-10.20) µg/L, [n=31] | 2.67 | |
3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid (CMPF) | protein-bound | 4.60 (+/-1.80) (3.61-7.70) mg/L, [n=29], p=0.00, D:A | 25.95 (+/-10.23) (3.70-94.00) mg/L, [n=63], p=0.00, D:C | 5.64 | |
2-Octenal | water-soluble | 26.08 (+/-16.38) µg/L, [n=20] | 32.51 (+/-21.16) µg/L, [n=17] | 1.25 | |
2-Nonenal | water-soluble | 18.48 (+/-5.17) µg/L, [n=20] | 101.78 (+/-58.38) µg/L, [n=17] | 5.51 | |
Hippuric acid (total) | protein-bound | 3.00 (+/-2.00) mg/L, [n=7] | 109.43 (+/-64.66) (67.00-247.00) mg/L, [n=37], p=0.00, D:B | 36.48 | |
Erythritol | water-soluble | 0.45 (+/-0.14) (0.22-0.75) mg/L, [n=33], D:B | 6.51 (+/-9.17) (2.00-37.00) mg/L, [n=28], D:D | 14.47 | |
Fructoselysine | protein-bound | 81.00 (+/-8.32) (68.68-102.56) mg/L, [n=19] | 58.10 (+/-10.80) mg/L, [n=10] | 0.72 | |
Hypoxanthine | water-soluble | 1.48 (+/-0.50) (1.47-1.50) mg/L, [n=290], p=0.61, D:A | 1.92 (+/-1.38) (0.92-2.67) mg/L, [n=103], p=0.10, D:A | 1.29 | |
Glyoxal | protein-bound | 19.04 (+/-12.04) µg/L, [n=18] | 221.00 (+/-28.00) µg/L, [n=20] | 11.61 | |
Indican | protein-bound | 1.00 (+/-0.40) mg/L, [n=4] | 27.30 (+/-13.30) mg/L, [n=31] | 27.30 | |
1-Methylinosine | water-soluble | 13.50 (+/-3.90) µg/L, [n=10] | 620.40 (+/-203.40) µg/L, [n=14] | 45.96 | |
2-Heptenal | water-soluble | 17.70 (+/-5.33) µg/L, [n=20] | 54.66 (+/-33.49) µg/L, [n=17] | 3.09 | |
Guanylin | middle | 0.05 (+/-0.02) (0.05-0.05) µg/L, [n=62], p=0.69, D:A | 10.73 (+/-4.99) (6.16-13.30) µg/L, [n=25], p=0.00, D:A | 225.66 | |
Heptanal | water-soluble | 51.07 (+/-11.17) µg/L, [n=20] | 61.10 (+/-44.11) µg/L, [n=17] | 1.20 | |
Hexanal | water-soluble | 21.70 (+/-10.80) µg/L, [n=20] | 51.70 (+/-33.00) µg/L, [n=17] | 2.38 | |
2-Hexenal | water-soluble | 22.05 (+/-6.56) µg/L, [n=20] | 61.74 (+/-20.48) µg/L, [n=17] | 2.80 | |
4-HO-Hexenal | water-soluble | 25.08 (+/-9.87) µg/L, [n=20] | 63.84 (+/-25.31) µg/L, [n=17] | 2.55 | |
Dimethylglycine | water-soluble | 381.10 µg/L, [n=33] | 576.80 (?-1040.30) µg/L, [n=18] | 1.51 | |
Indole-3-acetic acid (free) | protein-bound | 0.50 (+/-0.30) mg/L, [n=21] | 1.26 (+/-0.83) (0.44-1.50) mg/L, [n=49], p=0.00, D:B | 2.52 | |
4-HO-Octenal | water-soluble | 10.65 (+/-3.56) µg/L, [n=20] | 27.83 (+/-13.79) µg/L, [n=17] | 2.61 | |
4-Pyridone-3-carboxamide-1-β-D-ribonucleoside | water-soluble | 3.54 (+/-1.63) µg/L, [n=9] | 156.12 (+/-169.18) µg/L, [n=11] | 44.10 | |
8-Hydroxy-2’-deoxyguanosine | water-soluble | 0.64 (+/-0.23) (0.20-1.26) µg/L, [n=85] | 0.82 (+/-0.25) µg/L, [n=47] | 1.28 | |
Angiogenin | protein-bound | 308.00 (104.60-615.10) µg/L, [n=208] | 803.00 (+/-74.00) µg/L, [n=12] | 2.61 | |
Arab(in)itol | water-soluble | 0.37 (+/-0.12) (0.16-0.63) mg/L, [n=33], D:B | 8.75 (+/-5.89) (0.80-15.00) mg/L, [n=28], D:C | 23.64 | |
Argininic Acid | water-soluble | 16.59 (+/-5.60) (16.59-77.00) µg/L, [n=16], D:B | 65.82 (+/-33.36) (40.25-197.80) µg/L, [n=31], D:B | 3.97 | |
Basic fibroblast growth factor (BFGF) | middle | 0.21 (+/-0.09) ng/L, [n=23] | 1.35 (0.20-21.50) ng/L, [n=32] | 6.43 | |
Calcitonin gene-related peptide (CGRP) | middle | 185.66 (+/-11.37) ng/L, [n=20] | 164.44 (+/-35.95) ng/L, [n=10] | 0.89 | |
4-HO-Decenal | water-soluble | 10.25 (+/-7.12) µg/L, [n=20] | 36.55 (+/-22.27) µg/L, [n=17] | 3.57 | |
Delta-sleep Inducing Peptide | middle | 0.90 (+/-0.29) µg/L, [n=12] | 1.50 (+/-0.90) µg/L, [n=7] | 1.67 | |
4-Decenal | water-soluble | 15.86 (+/-5.25) µg/L, [n=20] | 53.90 (+/-26.80) µg/L, [n=20] | 3.40 | |
Clara cell protein (CC16) | middle | 0.01 (+/-0.01) mg/L, [n=117] | 3.03 (+/-1.37) (2.80-12.50) mg/L, [n=26], p=0.50, D:B | 218.04 | |
Complement Factor D | middle | 1.90 (+/-0.50) mg/L, [n=5] | 21.35 (+/-6.03) (11.40-27.70) mg/L, [n=37], p=0.00, D:A | 11.23 | |
Creatine | water-soluble | 9.70 (+/-3.30) mg/L, [n=24] | 134.00 (+/-30.30) (?-235.80) mg/L, [n=29] | 13.81 | |
3-Deoxyglucosone | protein-bound | 0.30 (+/-0.10) mg/L, [n=30] | 1.70 (+/-1.00) mg/L, [n=27] | 5.67 | |
4-HO-Nonenal | water-soluble | 16.38 (+/-8.99) µg/L, [n=20] | 117.31 (+/-47.74) µg/L, [n=17] | 7.16 | |
Cytidine | water-soluble | 468.00 µg/L, [n=1] | 683.30 (+/-287.80) (?-1263.60) µg/L, [n=7] | 1.46 | |
Decanal | water-soluble | 17.16 (+/-4.95) µg/L, [n=20] | 23.40 (+/-8.81) µg/L, [n=17] | 1.36 | |
Degranulation Inhibiting Protein I | middle | 321.70 (+/-59.70) µg/L, [n=23] | 713.70 (+/-390.00) (?-1631.40) µg/L, [n=125] | 2.22 | |
Cystatin C | middle | 0.70 (+/-0.12) mg/L, [n=56] | 11.13 (+/-4.48) (2.80-41.10) mg/L, [n=220], p=0.00, D:C | 15.90 | |
λ-Ig Light Chain | middle | 31.00 (+/-11.20) mg/L, [n=15] | 87.00 (+/-60.90) (?-328.00) mg/L, [n=104] | 2.81 | |
Indole-3-acetic acid (total) | protein-bound | 17.50 (+/-17.50) µg/L, [n=7] | 1004.74 (+/-702.49) (875.00-9076.90) µg/L, [n=95], p=0.00, D:D | 57.41 | |
Uric Acid | water-soluble | 40.50 (+/-13.90) mg/L, [n=12] | 50.60 (+/-15.60) (6.23-146.70) mg/L, [n=75], p=0.00, D:C | 1.25 | |
Phenol | protein-bound | 0.41 (+/-0.19) (0.19-0.60) mg/L, [n=22], p=0.00, D:B | 2.64 (+/-2.27) (1.00-12.40) mg/L, [n=36], p=0.07, D:C | 6.39 | |
Phenylacetylglutamine | water-soluble | 0.40 (+/-0.20) mg/L, [n=16] | 52.25 (+/-29.85) (52.00-120.60) mg/L, [n=31], p=0.89, D:A | 130.63 | |
Putrescine | protein-bound | 10.13 (+/-5.14) (4.36-21.10) µg/L, [n=29], p=0.00, D:B | 59.03 (+/-23.45) (8.01-77.40) µg/L, [n=34], p=0.00, D:C | 5.83 | |
Quinolinic Acid | protein-bound | 0.10 (+/-0.05) mg/L, [n=10] | 1.50 (+/-0.90) mg/L, [n=54] | 15.00 | |
Sorbitol | water-soluble | 0.16 (+/-0.11) (0.06-0.60) mg/L, [n=33], D:C | 1.81 (+/-1.55) (0.10-3.10) mg/L, [n=22], D:C | 11.31 | |
Substance P | middle | 179.67 (+/-87.87) (45.40-246.80) ng/L, [n=72], p=0.00, D:B | 2.70 (+/-0.13) ng/L, [n=11] | 0.02 | |
Taurocyamine | water-soluble | 1.32 (+/-1.39) mg/L, [n=10] | 5.36 (+/-2.24) mg/L, [n=15] | 4.06 | |
Threitol | water-soluble | 200.00 (+/-60.00) (100.00-370.00) µg/L, [n=33], D:B | 1501.92 (+/-602.28) (300.00-5697.40) µg/L, [n=28], D:C | 7.51 | |
Trimethylamine-N-oxide | water-soluble | 2.83 (+/-1.53) mg/L, [n=10] | 7.49 (+/-2.39) mg/L, [n=10] | 2.64 | |
Tumor Necrosis Factor Alpha (TNF) | middle | 13.30 (+/-3.00) ng/L, [n=28] | 206.35 (+/-176.03) (4.90-5600.00) ng/L, [n=337], p=0.00, D:D | 15.51 | |
Uridine | water-soluble | 1.50 (+/-1.30) mg/L, [n=30] | 9.80 (+/-11.40) mg/L, [n=22] | 6.53 | |
Oxalate | water-soluble | 0.30 (+/-0.10) mg/L, [n=8] | 2.41 (+/-0.97) (2.08-4.90) mg/L, [n=69], p=0.00, D:A | 8.02 | |
Uroguanylin | middle | 8.34 (+/-0.50) ng/L, [n=13] | 354.57 (+/-46.59) (353.62-361.79) ng/L, [n=86], p=0.53, D:A | 42.51 | |
Vascular endothelial growth factor (VEGF) | protein-bound | 359.00 (+/-168.00) ng/L, [n=21] | 529.00 (+/-455.00) ng/L, [n=38] | 1.47 | |
Vasoactive intestinal peptide (VIP) | middle | 34.58 (+/-2.33) ng/L, [n=16] | 75.48 (+/-27.33) ng/L, [n=10] | 2.18 | |
Vasopressin (ADH) | middle | 5.32 (+/-4.00) ng/L, [n=37] | 5.20 (+/-2.88) (1.70-10.80) ng/L, [n=26], p=0.00, D:B | 0.98 | |
Xanthosine | water-soluble | 23.90 (+/-12.80) µg/L, [n=10] | 96.60 (+/-62.90) µg/L, [n=11] | 4.04 | |
α-keto-δ-Guanidinovaleric Acid | water-soluble | 8.23 (+/-2.63) µg/L, [n=16] | 39.79 (31.14-60.55) µg/L, [n=20] | 4.83 | |
α-N-Acetylarginine | water-soluble | 18.10 (+/-24.80) µg/L, [n=16] | 328.30 (+/-142.60) (?-4580.00) µg/L, [n=13] | 18.14 | |
α1-Acid glycoprotein | protein-bound | 0.63 (+/-0.19) g/L, [n=28] | 1.17 (+/-0.39) g/L, [n=29] | 1.86 | |
β-Endorphin | middle | 173.30 ng/L, [n=10] | 157.16 (+/-50.12) (22.90-492.00) ng/L, [n=37], p=0.00, D:C | 0.91 | |
β-Guanidinopropionic Acid | water-soluble | 3.30 µg/L, [n=24] | 28.80 (+/-18.30) µg/L, [n=29] | 8.73 | |
β-Lipotropin | water-soluble | 2.92 (+/-0.31) (2.81-55.30) ng/L, [n=2], D:D | 50.58 (+/-15.30) (25.68-125.30) ng/L, [n=8], p=0.00, D:B | 17.29 | |
Pentosidine | protein-bound | 51.60 (+/-18.80) µg/L, [n=19] | 796.53 (+/-407.16) (579.50-2964.00) µg/L, [n=35], p=0.20, D:B | 15.44 | |
Osteocalcin | protein-bound | 9.50 (1.00-18.00) µg/L, [n=100] | 356.40 (+/-607.40) µg/L, [n=10] | 37.52 | |
Indoxyl-β-D-glucoronide | protein-bound | 0.95 (+/-0.39) mg/L, [n=15] | 2.93 (+/-2.94) mg/L, [n=10] | 3.09 | |
Methionine-Enkephalin | middle | 18.30 ng/L, [n=10] | 32.20 (?-75.50) ng/L, [n=22] | 1.76 | |
Inosine | water-soluble | 0.03 (+/-0.01) mg/L, [n=22] | 1.90 (+/-0.40) mg/L, [n=12] | 64.45 | |
Insulin-like growth factor 1 (IGF-1) | protein-bound | 181.00 (+/-49.20) µg/L, [n=17] | 220.00 (+/-93.00) µg/L, [n=20] | 1.22 | |
Interleukin-10 | protein-bound | 7.10 (+/-1.50) (4.80-9.80) ng/L, [n=18] | 10.60 (+/-6.00) ng/L, [n=71] | 1.49 | |
Interleukin-18 | middle | 142.13 (+/-48.10) (2.00-193.44) ng/L, [n=22], p=0.00, D:C | 201.82 (+/-169.32) (13.00-508.47) ng/L, [n=58], p=0.00, D:C | 1.42 | |
Interleukin-1β | middle | 160.00 ng/L, [n=15] | 235.59 (+/-92.39) (2.60-428.00) ng/L, [n=64], p=0.00, D:C | 1.47 | |
Interleukin-6 | middle | 13.30 (+/-3.10) ng/L, [n=28] | 71.48 (+/-104.13) (3.60-102.80) ng/L, [n=330], p=0.00, D:C | 5.37 | |
γ-guanidinobutyric Acid | water-soluble | 3.60 µg/L, [n=24] | 33.30 (+/-16.00) (?-1750.00) µg/L, [n=30] | 9.25 | |
Kynurenic Acid | protein-bound | 5.48 (+/-1.32) µg/L, [n=7] | 151.01 (+/-76.36) µg/L, [n=9] | 27.55 | |
Malondialdehyde (MDA) | water-soluble | 257.70 (+/-81.70) µg/L, [n=30] | 274.39 (+/-133.67) (7.81-428.80) µg/L, [n=26], D:C | 1.06 | |
Mannitol | water-soluble | 0.41 (+/-0.45) (0.09-2.16) mg/L, [n=33], D:C | 14.40 (+/-16.37) (0.80-26.00) mg/L, [n=28], D:C | 35.12 | |
Melatonin | protein-bound | 26.50 (+/-7.10) ng/L, [n=35] | 175.80 (+/-130.20) ng/L, [n=13] | 6.63 | |
Methylglyoxal | protein-bound | 47.00 (+/-12.00) µg/L, [n=15] | 110.00 (+/-18.00) µg/L, [n=20] | 2.34 | |
Orotidine | water-soluble | 1.20 (+/-1.60) mg/L, [n=30] | 20.20 (+/-13.50) mg/L, [n=22] | 16.83 | |
N(6)-Carboxymethyllysine (CML) | protein-bound | 1.10 (+/-0.30) mg/L, [n=24] | 3.99 (+/-1.59) (1.84-18.50) mg/L, [n=128], p=0.00, D:C | 3.62 | |
N-methyl-2-pyridone-5-carboxamide | water-soluble | 0.13 (+/-0.03) mg/L, [n=19] | 2.36 (+/-0.88) mg/L, [n=21] | 18.70 | |
N-methyl-4-pyridone-3-carboxamide | water-soluble | 39.52 (+/-13.68) µg/L, [n=19] | 319.20 (+/-395.20) µg/L, [n=21] | 8.08 | |
N2,N2-Dimethylguanosine | water-soluble | 9.00 (+/-4.70) µg/L, [n=10] | 236.40 (+/-89.70) µg/L, [n=14] | 26.27 | |
N4-Acetylcytidine | water-soluble | 57.00 (+/-17.10) µg/L, [n=10] | 159.60 (+/-30.80) µg/L, [n=14] | 2.80 | |
N6-Methyladenosine | water-soluble | 18.50 (+/-8.40) µg/L, [n=10] | 70.30 (+/-53.30) µg/L, [n=17] | 3.80 | |
N6-Threonylcarbamoyladenosine | water-soluble | 35.50 (+/-27.20) µg/L, [n=10] | 378.00 (+/-151.20) µg/L, [n=17] | 10.65 | |
Neopterin | water-soluble | 1.38 (+/-0.47) µg/L, [n=10] | 83.25 (+/-10.78) µg/L, [n=12] | 60.33 | |
Nicotinamide | water-soluble | 3.17 (+/-1.22) µg/L, [n=19] | 35.38 (+/-29.28) µg/L, [n=21] | 11.16 | |
Nonanal | water-soluble | 37.35 (+/-23.29) µg/L, [n=20] | 68.87 (+/-26.84) µg/L, [n=17] | 1.84 | |
Orotic Acid | water-soluble | 0.50 (+/-1.40) mg/L, [n=30] | 6.70 (+/-16.00) mg/L, [n=22] | 13.40 | |
Kinurenine | protein-bound | 391.00 µg/L, [n=7] | 686.40 (+/-178.90) µg/L, [n=21] | 1.76 | |